Cryo-Cell International, Inc. (CCEL)
ASE · Medical Care Facilities
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Peers in Medical Care Facilities
All in industry →HCA Healthcare, Inc.
Tenet Healthcare Corporation
Fresenius Medical Care AG
The Ensign Group, Inc.
Universal Health Services, Inc.
Encompass Health Corporation
DaVita Inc.
PACS Group, Inc.
Chemed Corporation
Option Care Health, Inc.
Recent press releases
Cryo-Cell International, Inc. has not issued a press release in this window.
SEC filings
All filings →Cryo-Cell International, Inc. has not filed an SEC document in this window.
Insider trades
All insider trades →Cryo-Cell International, Inc. has no reported insider trades in the last 90 days.
Institutional holders
All holders →No 13F holdings have been reported for Cryo-Cell International, Inc. in this window.